These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13875639)

  • 1. [Treatment of an operated patient with an anabolic steroid by oral route: 4-hydroxy-17alpha-methyltestosterone].
    CALA G
    Minerva Chir; 1961 Nov; 16():1433-6. PubMed ID: 13875639
    [No Abstract]   [Full Text] [Related]  

  • 2. [4-Hydroxy-17alpha-methyltestosterone, new oral anabolic steroid].
    MIROUZE J
    Sem Hop; 1961 Sep 14-20; 37():2567-71. PubMed ID: 14474477
    [No Abstract]   [Full Text] [Related]  

  • 3. [The protein-anabolic properties of 4-hydroxy-17alpha-methyltestosterone in some forms of osseous atrophy].
    QUAINI L; VALOBRA M
    Minerva Ortop; 1961 Oct; 12():711-7. PubMed ID: 14489378
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activity of a new oral steroid with anabolic action (4-hydroxy-17- alpha-methyltestosterone) on the serum protein pattern, on internal pressure of the tissues and on the function of the memory in patients of advanced age].
    MARS G
    G Gerontol; 1960 Nov; 8():1000-8. PubMed ID: 13767141
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anabolic and endocrine effects of a new steroid, 4-hydroxy-17-a-alpha-methyltestosterone, in the aged].
    BECK H; BERTHAUX P
    Sem Hop; 1961 Oct; 37():2728-30. PubMed ID: 13866271
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anabolic activity and effect on water-electrolyte balance of 1-dehydro-17alpha-methyltestosterone in small doses].
    MARTINA G; RASETTI L
    Minerva Med; 1961 Feb; 52():388-9. PubMed ID: 13767436
    [No Abstract]   [Full Text] [Related]  

  • 7. The anabolising effect of 4-hydroxy-17alpha-methyltestosterone.
    BALDRATTI G; ARCARI G
    Panminerva Med; 1962 Mar; 4():137-9. PubMed ID: 13864322
    [No Abstract]   [Full Text] [Related]  

  • 8. Endocrine characterization of the designer steroid methyl-1-testosterone: investigations on tissue-specific anabolic-androgenic potency, side effects, and metabolism.
    Parr MK; Blatt C; Zierau O; Hess C; Gütschow M; Fusshöller G; Opfermann G; Schänzer W; Diel P
    Endocrinology; 2011 Dec; 152(12):4718-28. PubMed ID: 21990312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The action of 4-hydroxy-17alpha-methyltestosterone on "DOCA-induced hypertension")].
    CLINI V; PENATI MR; SALA G; TUROLLA E
    Sperimentale; 1961; 111():345-54. PubMed ID: 13879964
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endocrine-gynecologic observations during treatment with 4-hydroxy-17alpha-methyltestosterone].
    MARINACCIO L
    Minerva Ginecol; 1961 Feb; 13():197-201. PubMed ID: 13766780
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of 4-hydroxy-17alpha-methyl-testosterone on the nitrogen balance.
    BENEDETTI A; BUCCIANTE G; POLI D
    Panminerva Med; 1962 Mar; 4():139-41. PubMed ID: 13867119
    [No Abstract]   [Full Text] [Related]  

  • 12. [4-CHLORO-DELTA-1-METHYLTESTOSTERONE (ORAL TURINABOL), A NEW EFFECTIVE ORAL ANABOLIC STEROID].
    DOERNER G
    Dtsch Gesundheitsw; 1965 Apr; 20():670-4. PubMed ID: 14304129
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex-specific effects of chronic anabolic androgenic steroid treatment on GABA(A) receptor expression and function in adolescent mice.
    Penatti CA; Porter DM; Jones BL; Henderson LP
    Neuroscience; 2005; 135(2):533-43. PubMed ID: 16112473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of urinary metabolites of 17alpha-methyltestosterone.
    RONGONE EL; SEGALOFF A
    J Biol Chem; 1962 Apr; 237():1066-7. PubMed ID: 14493684
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of protein metabolism and electrolyte balance in man during treatment with 1-dehydro-17alpha-methyltestosterone].
    MARTINA G; MORRA C; RASETTI L
    Minerva Med; 1960 Mar; 51():971-7. PubMed ID: 14421757
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical observations on the anabolic action of 1-dehydro-17 alpha-methyl-testosterone a new non-virilizing steroid].
    RAPOSO P
    J Pediatr (Rio J); 1960 Jun; 25():273-80. PubMed ID: 13739585
    [No Abstract]   [Full Text] [Related]  

  • 17. [Exploration of the turnover of erythrocytic P during treatment with 1-dehydro-17alpha-methyltestosterone].
    JACONO G; DE LUCA R; BRANCACCIO A; D'ALESSANDRO B; GALDIERO F
    Folia Endocrinol Mens Incretologia Incretoterapia; 1960 Dec; 13(6)Suppl():39-41. PubMed ID: 14450797
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic activity by the oral route of a new derivative of testosterone: the hexylenolic ether of methyltestosterone].
    NOVELLI E; PINACCI U
    Gazz Med Ital; 1962 Apr; 121():99-110. PubMed ID: 14480557
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protein-anabolizing steroids with special reference to the use in pediatrics of a new anabolic steroid: 4-hydroxy-17 alpha-methyltestosterone].
    RAINERO L
    Minerva Pediatr; 1961 Mar; 13():318-24. PubMed ID: 13739190
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effectes of ethinyl estradiol, 17alpha-ethyl-19-nortestosterone and methyltestosterone on the plasma clearance on infused cortisol.
    MARKS LJ; BENJAMIN G; DUNCAN FJ; O'SULLIVAN VI
    J Clin Endocrinol Metab; 1961 Jul; 21():826-32. PubMed ID: 13766952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.